Q4 2022 Holdings
Filed 2023-02-13 | 8 holdings | $234.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kinnate Biopharma Inc. | COM | 49705R105 | $59.0M | 9,671,643 | 25.2% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $44.2M | 2,808,034 | 18.9% |
| Pharvaris N.V.(PHVS) | COM | N69605108 | $36.5M | 3,246,926 | 15.6% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $34.7M | 10,000,000 | 14.8% |
| Kura Oncology, Inc.(KURA) | COM | 50127T109 | $23.0M | 1,849,947 | 9.8% |
| Syndax Pharmaceuticals, Inc.(SNDX) | COM | 87164F105 | $22.3M | 875,000 | 9.5% |
| Cymabay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $11.2M | 1,787,094 | 4.8% |
| Quantum-Si Incorporated(QSI) | COM CL A | 74765K105 | $3.2M | 1,771,249 | 1.4% |